MARATTO

article · Frontiers in Immunology

Estimation of PfRh5-based vaccine efficacy in asymptomatic Plasmodium falciparum patients from high-endemic areas of Tanzania using genetic and antigenicity variation screening

20246 citationsOpen accessUniversity of Dar es Salaam

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

These findings underscore the need for future PfRh5-based vaccines to consider for increasing genetic variation and geographical differences in humoral immune responses.

Research topics

  • Malaria Research and Control
  • vaccines and immunoinformatics approaches
  • Mosquito-borne diseases and control

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3389/fimmu.2024.1495513

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.